Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
AstraZeneca
Chubb
Queensland Health
Colorcon
McKesson
Deloitte
Farmers Insurance

Generated: December 10, 2018

DrugPatentWatch Database Preview

Drug Price Trends for EFAVIRENZ

« Back to Dashboard

Drug Price Trends for EFAVIRENZ

Average Pharmacy Cost for EFAVIRENZ

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
EFAVIRENZ 600 MG TABLET 00378-2233-93 20.23743 EA 2018-11-21
EFAVIRENZ 600 MG TABLET 69097-0301-02 20.23743 EA 2018-11-21
EFAVIRENZ 600 MG TABLET 31722-0504-30 20.23743 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for EFAVIRENZ

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
SUSTIVA 50MG CAP Bristol-Myers Squibb Company 00056-0470-30 30 57.99 1.93300 EA 2018-05-01 - 2023-04-30 Big4
SUSTIVA 50MG CAP Bristol-Myers Squibb Company 00056-0470-30 30 82.18 2.73933 EA 2018-05-01 - 2023-04-30 FSS
SUSTIVA 200MG CAP Bristol-Myers Squibb Company 00056-0474-92 90 687.36 7.63733 EA 2018-05-01 - 2023-04-30 Big4
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Chubb
Express Scripts
Citi
Farmers Insurance
McKinsey
Dow
Fuji
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.